Electroacupuncture and Rosiglitazone Combined Therapy as a Means of Treating Insulin Resistance and Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Figure 3
Effects of combined therapy or single therapy on insulin sensitivity as evaluated by HOMA index among type 2 diabetic patients before and after treatment. TZD + EA = patients receiving 8 mg rosiglitazone stat and electroacupuncture; TZD = patients receiving 8 mg rosiglitazone stat only; HOMA index = (fasting plasma glucose fasting plasma insulin)/22.5; Wilcoxon signed-rank test was used to assess differences in the means of each group, .
